{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T06:33:01Z","timestamp":1778653981361,"version":"3.51.4"},"reference-count":10,"publisher":"The Endocrine Society","issue":"9","funder":[{"DOI":"10.13039\/501100005275","name":"Region Hovedstaden","doi-asserted-by":"publisher","award":["E-22325-06"],"award-info":[{"award-number":["E-22325-06"]}],"id":[{"id":"10.13039\/501100005275","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Context<\/jats:title><jats:p>Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency (LCHADD) affects oxidation of long-chain fatty acids (FAO) and is associated with risk of metabolic crises and episodic rhabdomyolysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case Description<\/jats:title><jats:p>We present the cases of two patients with LCHADD. Patient 1 (male, 26 years old) was severely affected by muscle weakness and neuropathy. He was diagnosed at age 20 years and was nonadherent to standard dietary management. MRI revealed significant fat replacement of muscle in both calves. Patient 2 (female, 15 years old) was diagnosed at age 1 year. She had no muscle weakness and was compliant with the recommended diet. Compared with healthy persons, both patients had reduced FAO and palmitate oxidation, measured with indirect calorimetry and stable isotope technique during a submaximal cycle ergometer test. Patient 2 had some residual capacity to increase FAO and a compensatory higher carbohydrate oxidation, which ensured a near-normal exercise capacity. Patient 1 was unable to increase FAO and could only complete 23 minutes of exercise, vs 60 minutes by patient 2 and healthy persons. In both, 10% IV infusion of glucose (IV-glucose) during exercise increased carbohydrate oxidation slightly, but endurance was not improved, which likely relates to the fixed weakness in patient 1 and because the residual FAO was suppressed by the glucose infusion in both.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The two patients illustrate that FAO is impaired and carbohydrate oxidation is elevated during exercise in patients affected by LCHADD, compared with healthy persons, but IV-glucose has no beneficial effect on exercise tolerance in LCHADD.<\/jats:p><\/jats:sec>","DOI":"10.1210\/jc.2019-00453","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T13:03:26Z","timestamp":1555419806000},"page":"3610-3613","source":"Crossref","is-referenced-by-count":2,"title":["Impaired Fat Oxidation During Exercise in Long-Chain Acyl-CoA Dehydrogenase Deficiency Patients and Effect of IV-Glucose"],"prefix":"10.1210","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0145-1084","authenticated-orcid":false,"given":"Karen Lindhardt","family":"Madsen","sequence":"first","affiliation":[{"name":"Department of Neurology, Copenhagen Neuromuscular Center, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4566-4156","authenticated-orcid":false,"given":"Mads Godtfeldt","family":"Stemmerik","sequence":"additional","affiliation":[{"name":"Department of Neurology, Copenhagen Neuromuscular Center, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8571-5480","authenticated-orcid":false,"given":"Astrid Emilie","family":"Buch","sequence":"additional","affiliation":[{"name":"Department of Neurology, Copenhagen Neuromuscular Center, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanna Scharff","family":"Poulsen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Copenhagen Neuromuscular Center, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6091-7879","authenticated-orcid":false,"given":"Allan Meldgaard","family":"Lund","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Centre for Inherited Metabolic Diseases, Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Clinical Genetics, Centre for Inherited Metabolic Diseases, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6144-8544","authenticated-orcid":false,"given":"John","family":"Vissing","sequence":"additional","affiliation":[{"name":"Department of Neurology, Copenhagen Neuromuscular Center, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2019,4,16]]},"reference":[{"issue":"4","key":"2019071705264162900_bib1","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1023\/A:1005556207210","article-title":"Recognition and management of fatty acid oxidation defects: a series of 107 patients","volume":"22","author":"Saudubray","year":"1999","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"2019071705264162900_bib2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s10545-009-1126-8","article-title":"Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop","volume":"32","author":"Spiekerkoetter","year":"2009","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"2019071705264162900_bib3","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s10545-009-1125-9","article-title":"Management and outcome in 75 individuals with long-chain fatty acid oxidation defects: results from a workshop","volume":"32","author":"Spiekerkoetter","year":"2009","journal-title":"J Inherit Metab Dis"},{"issue":"24","key":"2019071705264162900_bib4","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1212\/WNL.0000000000004752","article-title":"Muscle glycogen synthesis and breakdown are both impaired in glycogenin-1 deficiency","volume":"89","author":"Stemmerik","year":"2017","journal-title":"Neurology"},{"issue":"1","key":"2019071705264162900_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/jmd2.12024","article-title":"Impaired fat oxidation during exercise in multiple acyl-CoA dehydrogenase deficiency","volume":"46","author":"Madsen","year":"2019","journal-title":"JIMD Rep"},{"issue":"4","key":"2019071705264162900_bib6","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1210\/jc.2012-3791","article-title":"Patients with medium-chain acyl-coenzyme a dehydrogenase deficiency have impaired oxidation of fat during exercise but no effect of L-carnitine supplementation","volume":"98","author":"Madsen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019071705264162900_bib7","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ana.24743","article-title":"Contractile properties are disrupted in Becker muscular dystrophy, but not in limb girdle type 2I","volume":"80","author":"L\u00f8kken","year":"2016","journal-title":"Ann Neurol"},{"issue":"1","key":"2019071705264162900_bib8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ymgme.2011.09.030","article-title":"Substrate oxidation and cardiac performance during exercise in disorders of long chain fatty acid oxidation","volume":"105","author":"Behrend","year":"2012","journal-title":"Mol Genet Metab"},{"issue":"7","key":"2019071705264162900_bib9","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1212\/WNL.59.7.1046","article-title":"Exercise tolerance in carnitine palmitoyltransferase II deficiency with IV and oral glucose","volume":"59","author":"\u00d8rngreen","year":"2002","journal-title":"Neurology"},{"issue":"3","key":"2019071705264162900_bib10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1212\/01.wnl.0000265854.41013.84","article-title":"Effects of IV glucose and oral medium-chain triglyceride in patients with VLCAD deficiency","volume":"69","author":"\u00d8rngreen","year":"2007","journal-title":"Neurology"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/jc.2019-00453\/28377039\/jc.2019-00453.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/9\/3610\/28940659\/jc.2019-00453.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T20:03:56Z","timestamp":1694808236000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/104\/9\/3610\/5450712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,16]]},"references-count":10,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,4,16]]},"published-print":{"date-parts":[[2019,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2019-00453","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,9]]},"published":{"date-parts":[[2019,4,16]]}}}